Drug profile · INN
donidalorsen
DAWNZERA
donidalorsen (DAWNZERA) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Blood and blood forming organs (B06) B06AC
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — donidalorsen
- Class
- Blood and blood forming organs (B06)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
donidalorsen (DAWNZERA) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN donidalorsen
Brand DAWNZERA
Therapeutic class Blood and blood forming organs (B06)
ATC code B06AC
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is donidalorsen?
donidalorsen (DAWNZERA) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for donidalorsen?
DAWNZERA is a marketed brand name for donidalorsen. Check FDA Drugs@FDA for the current US label holder and prescribing information.